Gyre Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell GYRE and other ETFs, options, and stocks.About GYRE
Gyre Therapeutics, Inc. operates as a biopharmaceutical company. It is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis).
GYRE Key Statistics
Stock Snapshot
With a market cap of 675.27M, Gyre Therapeutics(GYRE) trades at $7.39. The stock has a price-to-earnings ratio of 328.44.
On 2026-04-11, Gyre Therapeutics(GYRE) stock moved within a range of $7.19 to $7.41. With shares now at $7.39, the stock is trading +2.8% above its intraday low and -0.3% below the session's peak.
Trading activity shows a volume of 46.35K, compared to an average daily volume of 87.03K.
The stock's 52-week range extends from a low of $6.57 to a high of $11.78.
The stock's 52-week range extends from a low of $6.57 to a high of $11.78.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.